Indian stock market closed lower on June 29, 2026, with Sensex falling 372 points and Nifty ending at 23,946 amid US-Iran ceasefire concerns, rising crude oil prices, and profit booking. Pharma stocks ...

The Nifty Pharma Index surged 2% to a fresh 52-week high, driven by strong gains in Dr Reddy’s, Cipla, Ajanta Pharma and ...

Dr. Reddy's Laboratories shares hit a fresh 52-week high as investors cheered its improving biologics pipeline, positive ...

Suzlon wins a 400 MW EPC wind project from Tata Power Renewables in Andhra Pradesh, strengthening its 1 GW+ partnership and ...

Turtlemint Fintech Solutions IPO lists at a discount on NSE and BSE despite strong QIB demand. Explore listing performance, ...

Asian markets closed mixed on June 29, 2026, with China and Hong Kong leading gains while India slipped below 24,000 amid profit-taking and ongoing US–Iran geopolitical tensions.

Bajaj Healthcare shares jumped 15% after becoming the first Indian company to receive SEC recommendation for Cenobamate tablets. Here's why investors are bullish despite mixed Q4 FY26 results.

HDFC Bank shares gained after Jefferies and JPMorgan reaffirmed bullish ratings following an independent legal review that ...

Why did Dr. Reddy's shares rise 5% despite receiving seven USFDA observations? Here's why investors remained bullish on the ...

Timing is everything in the market. Find the best time to invest in stocks by analyzing market trends, regular trading ...

Sensex surged over 900 points while Nifty reclaimed 24,050. Discover the 6 key reasons behind today's stock market rally, ...

Gold and silver surged to multi-week highs in June 2026 despite expectations that a US-Iran peace deal would reduce ...